Latest Breaking News On - Lepu biopharma co ltd - Page 1 : comparemela.com

HONG KONG, Feb. 22, 2023 /PRNewswire/ Lepu Biopharma Co., Ltd. (Stock Code: 02157.HK) and Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) today jointly announces a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class Claudin 18.2 antibody drug conjugate (ADC). Under the licence agreement, AstraZeneca will be responsible for the research, development, manufacture.

China
Lepu-biopharma
Keymed-biosciences
Bo-chen
Biosciences-inc
Astrazeneca
Keymed-biosciences-inc
Lepu-biopharma-co-ltd
Nasdaq
Stock-code
Chief-executive-officer
Board-chairman